Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
AMNIOEFFECT
Show more
Human biological amniotic membrane tissue intended for subsequent implantation; topical treatment in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; woun…
Class 5 – Pharmaceuticals & supplements
Status timeline
- 23 Oct 2021Application filedNew Application Entered
- 26 May 2022Assigned to an examining attorneyAssigned To Examiner
- 8 Jun 2022Approved for publicationApproved For Pub - Principal Register
- 12 Jul 2022Published for oppositionPublished For Opposition
- 6 Sep 2022Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 11 Oct 2022Statement of use filedTeas Statement Of Use Received
- 28 Nov 2022Statement of use acceptedAllowed Principal Register - Sou Accepted
- 29 Nov 2022Statement of use acceptedNotice Of Acceptance Of Statement Of Use E-Mailed
- 3 Jan 2023Registered on the Principal RegisterRegistered-Principal Register
All 16 events
| 2023-01-03 | Registered-Principal Register |
| 2023-01-03 | Notice Of Registration Confirmation Emailed |
| 2022-11-29 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2022-11-28 | Allowed Principal Register - Sou Accepted |
| 2022-10-27 | Case Assigned To Intent To Use Paralegal |
| 2022-10-27 | Statement Of Use Processing Complete |
| 2022-10-11 | Teas Statement Of Use Received |
| 2022-10-11 | Use Amendment Filed |
| 2022-09-06 | Noa Mailed - Sou Required From Applicant |
| 2022-07-12 | Published For Opposition |
| 2022-07-12 | Official Gazette Publication Confirmation E-Mailed |
| 2022-06-22 | Notification Of Notice Of Publication E-Mailed |
| 2022-06-08 | Approved For Pub - Principal Register |
| 2022-05-26 | Assigned To Examiner |
| 2021-11-05 | New Application Office Supplied Data Entered |
| 2021-10-23 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Human biological amniotic membrane tissue intended for subsequent implantation; topical treatment in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; woun…
First use anywhere 19 Sep 2022 · First use in commerce 19 Sep 2022
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 3 Jan 2023; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.